Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 4

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 4
---
 Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters                 |   72 |
| Item 13  | Certain                                                                                               
 Relationships and Related Transactions and Director Independence                                      |   72 |
| Item 14  | Principal                                                                                             
 Accountant Fees and Services                                                                          |   72 |
| Part IV  |                                                                                                       |   73 |
| Item 15  | Exhibits,                                                                                             
 Financial Statement Schedules                                                                         |   73 |
|          | Signatures                                                                                            
 and Certifications                                                                                    |   77 |

<div align='center'>i</div>

Cautionary Language Regarding Forward-Looking Statements and Industry Data

This Annual Report on Form 10-K
contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 regarding
the plans and objectives of management for future operations and market trends and expectations. Forward-looking statements can be identified
by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are based upon our current assumptions,
expectations and beliefs concerning future developments and their potential effect on our business. In some cases, you can identify forward-looking
statements by the following words: “may,” “could,” “would,” “should,” “expect,”
“intend,” “plan,” “anticipate,” “believe,” “approximately,” “estimate,”
“predict,” “project,” “potential” or the negative of these terms or other comparable terminology,
although the absence of these words does not necessarily mean that a statement is not forward-looking.

Forward-looking statements include,
but are not limited to, statements concerning:

| ● | Our ability to continue as a going concern and ability to raise additional capital;                                                                                                                                                                                                                   |
| ● | Our continuous incurrence of losses as a pre-clinical-stage biotechnology company with no products that have achieved regulatory approval;                                                                                                                                                            |
| ● | Our ability to generate revenue if we fail to develop marketable product;                                                                                                                                                                                                                             |
| ● | Our dependence on substantial additional financing to support the research, development, licensing, manufacture, and marketing of product candidates and products, and the possibility that unforeseen operational costs will arise;                                                                  |
| ● | The dilutive effect on stockholders’ ownership interests of the Company raising capital through an equity issuance in connection with future equity financing or equity debt agreements;                                                                                                              |
| ● | Our dependence on the services of experts, including third parties to research and develop product candidates in cooperation with our employees and officers